Researchers analyzed data from 28,299 COVID-19 patients hospitalized at 52 U.S. hospitals up to July 1.
Most hospitalized patients had at least one preexisting cardiovascular disease. About 50.4 percent of patients had hypertension. Of COVID-19 patients, 20.7 percent died in the hospital, but having heart failure increased mortality to 34.2 percent. Patients who had a cardiovascular event in a hospital also experienced high mortality rates.
Pharmaceutical Technology reported on the study Nov. 20, available here.
More articles on surgery center:
10 recent ASC leadership moves
Virginia ASC takes infection prevention to new level — 3 insights
Surgery Partners goes all-in on cardiology — 5 quotes on its quarterly performance
